NDC 0032-1212 – Creon

Pancrelipase Amylase 60000 [USP'U]/1; Pancrelipase Lipase 12000 [USP'U]/1; Pancrelipase Protease 38000 [USP'U]/1 · Capsule, Delayed Release Pellets · Oral

Human Prescription Drug 2 recalls

Product NDC0032-1212

Product details

Brand name
Creon
Generic name
Pancrelipase
Labeler
AbbVie Inc.
Dosage form
Capsule, Delayed Release Pellets
Route
Oral
Marketing category
BLA · BLA020725
Marketed since
April 30, 2009
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Creon →

Package NDC codes (3)

Package NDCDescriptionSince
0032-1212-01100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-1212-01)Apr 30, 2009
0032-1212-07250 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-1212-07)Apr 30, 2009
0032-1212-13 sample1 BOTTLE in 1 CARTON (0032-1212-13) / 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLENov 20, 2018

Recalls mentioning this NDC

Other Creon products